Condition: Asthma Acute · Asthma Exacerbation · Asthma · Sponsor: Massachusetts General Hospital
The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
This description comes directly from the study's public registry record.
Carlos A Camargo, MD, DrPH · 617-726-5276 · ccamargo@mgb.org
Always discuss trial participation with your own doctor first.
| MetroHealth | Cleveland, Ohio, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07166939